This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Search results

From Proteopedia

You searched for Axelsen,_P.H.

Jump to: navigation, search

There is no page with the exact title "Axelsen,_P.H.". The search results for "Axelsen,_P.H." are displayed below. You can create a page titled Axelsen,_P.H. (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Axelsen PH (41 bytes)
    1: List of pages with the keyword Axelsen PH
  2. Category:Axelsen, P H (43 bytes)
    1: List of pages with the keyword Axelsen, P H

Page text matches

  1. Category:Axelsen PH (41 bytes)
    1: List of pages with the keyword Axelsen PH
  2. 1aa5 (2,244 bytes)
    3: <StructureSection load='1aa5' size='340' side='right'caption='[[1aa5]], [[Resolution|resolution]] 0.8...
    4: == Structural highlights ==
    5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1AA5 FirstGlance]. <br>
    6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]...
    7: ...)-3-AMINO-2,3,6-TRIDEOXY-3-METHYL-ALPHA-L-ARABINO-HEXOPYRANOSE'>RER</scene></td></tr>
  3. 1c0q (4,067 bytes)
    2: ==COMPLEX OF VANCOMYCIN WITH 2-ACETOXY-D-PROPANOIC ACID==
    3: <StructureSection load='1c0q' size='340' side='right'caption='[[1c0q]], [[Resolution|resolution]] 1.0...
    4: == Structural highlights ==
    5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1C0Q FirstGlance]. <br>
    6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]...
  4. 1c0r (4,054 bytes)
    2: ==COMPLEX OF VANCOMYCIN WITH D-LACTIC ACID==
    3: <StructureSection load='1c0r' size='340' side='right'caption='[[1c0r]], [[Resolution|resolution]] 1.0...
    4: == Structural highlights ==
    5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1C0R FirstGlance]. <br>
    6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]...
  5. 1ghg (3,501 bytes)
    3: ...n load='1ghg' size='340' side='right'caption='[[1ghg]], [[Resolution|resolution]] 0.98&Aring;' scene=...
    4: == Structural highlights ==
    5: ...b> use [https://proteopedia.org/fgij/fg.htm?mol=1GHG FirstGlance]. <br>
    6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]...
    7: ... <scene name='pdbligand=OMZ:(BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE'>OMZ</scene>, <scene name='pdbli...
  6. 1qd8 (4,069 bytes)
    2: ==COMPLEX OF VANCOMYCIN WITH N-ACETYL GLYCINE==
    3: <StructureSection load='1qd8' size='340' side='right'caption='[[1qd8]], [[Resolution|resolution]] 1.0...
    4: == Structural highlights ==
    5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1QD8 FirstGlance]. <br>
    6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]...
  7. Sandbox c4 (1,400 bytes)
    1: ...rame='true' align='right' caption='Insert caption here' /><Structure load='1ACJ
    2: ' size='500' frame='true' align='right' caption='mi proteina' />estamos en proteopedia
    3: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    5: ...homimetic and a centrally acting cholinesterase inhibitor.
    7: ...terase inhibitor approved for the treatment of Alzheimer's disease.
  8. Sandbox c9 (716 bytes)
    1: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    3: ...homimetic and a centrally acting cholinesterase inhibitor.
    5: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    7: ... between the aromatic rings of tryptophan 84 and phenylalanine 330
    9: ...abatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding
  9. Sandbox c33 (2,463 bytes)
    1: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    3: ...homimetic and a centrally acting cholinesterase inhibitor.
    5: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    7: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330).
    9: ...matic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1...
  10. Sandbox c5 (856 bytes)
    1: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    3: ...homimetic and a centrally acting cholinesterase inhibitor.
    5: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    7: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 .
    11: ...matic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1...
  11. Sandbox c1 (1,179 bytes)
    1: ...rame='true' align='right' caption='Insert caption here' />
    2: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    4: ...homimetic and a centrally acting cholinesterase inhibitor.
    6: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    8: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330).
  12. Sandbox c2 (9,279 bytes)
    1: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    2: ...homimetic and a centrally acting cholinesterase inhibitor.
    3: ... between the aromatic rings of tryptophan 84 and phenylalanine 330
    6: ...matic residues in the active-site gorge of acetylcholinesterase.'<references/>
    8: [[http://www.proteopedia.org/taller/]]
  13. Sandbox c8 (1,233 bytes)
    1: ...ure load='1ACj' size='500' frame='true' align='right' caption='Estructura' />
    3: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    5: ...homimetic and a centrally acting cholinesterase inhibitor.
    7: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    9: ... between the aromatic rings of tryptophan 84 and phenylalanine 330
  14. Sandbox c20 (922 bytes)
    1: hola como estas?
    3: ...rame='true' align='right' caption='Insert caption here' />
    4: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    6: ...homimetic and a centrally acting cholinesterase inhibitor.
    8: ...terase inhibitor approved for the treatment of Alzheimer's disease.
  15. Sandbox c16 (1,321 bytes)
    2: ...ure load='1ACJ' size='300' frame='true' align='right' caption='acelit colinesterasa' />
    3: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    4: ...homimetic and a centrally acting cholinesterase inhibitor.
    6: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    8: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c16/Modifica...
  16. Sandbox c10 (1,419 bytes)
    1: ...rame='true' align='right' caption='Insert caption here' />
    2: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    4: ...homimetic and a centrally acting cholinesterase inhibitor.
    6: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    8: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330).
  17. Sandbox c6 (888 bytes)
    1: ...nica'' acetylcholinesterase (TcAChE) complexed with '''tacrine'''.<ref>PMID 654</ref>
    3: ...homimetic and a centrally acting cholinesterase inhibitor.
    5: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    7: ... between the aromatic rings of tryptophan 84 and phenylalanine 330
    12: ...matic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1...
  18. Sandbox c7 (1,116 bytes)
    1: ...ure load='1ACJ' size='500' frame='true' align='right' caption='estructura proteĆ­na curso' />
    2: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    4: ...homimetic and a centrally acting cholinesterase inhibitor.
    6: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    8: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 .<scene name='Sandbox_c7/Tacrine/1...
  19. Sandbox c99 (904 bytes)
    1: ...ure load='1acj' size='300' frame='true' align='right' caption='Mi structura favorita' />
    4: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.<ref>PMID 123</ref><ref>PMID 434343</ref>
    6: ...homimetic and a centrally acting cholinesterase inhibitor.
    8: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    10: ... between the aromatic rings of tryptophan 84 and phenylalanine 330
  20. Sandbox c14 (1,098 bytes)
    1: ...rame='true' align='right' caption='Insert caption here' />
    2: ...ornica acetylcholinesterase (TcAChE) complexed with tacrine.
    4: ...homimetic and a centrally acting cholinesterase inhibitor.
    6: ...terase inhibitor approved for the treatment of Alzheimer's disease.
    8: ... between the aromatic rings of tryptophan 84 and phenylalanine 330 (W84 and F330).

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools